Researchers racing to develop Paxlovid replacement
Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid — an antiviral medication that helps keep high-risk patients out of the hospital. Their report, which will appear in Science, shows that an alternative medication, a viral papain-like protease inhibitor, inhibits disease … Read more
